Fernando J Argento (Fernando Argento)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Positive Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

PharmacoEconomics - open

Infectious diseases and therapy

Revista peruana de medicina experimental y salud publica

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Agustín Ciapponi, Ariel Esteban Bardach, Carla Colaci, Federico Rodriguez Cairoli, Fernando J Argento, Ernesto Korbenfeld, Sebastian Garcia Marti
Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis. Revista peruana de medicina experimental y salud publica 41 (1) (2024)
Agustín Ciapponi, Ariel Esteban Bardach, Carla Colaci, Federico Rodriguez Cairoli, Fernando J Argento, Ernesto Korbenfeld, Sebastian Garcia Marti
Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis. Revista peruana de medicina experimental y salud publica 41 (1) (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Agustín Ciapponi, Ariel Esteban Bardach, Carla Colaci, Federico Rodriguez Cairoli, Fernando J Argento, Ernesto Korbenfeld, Sebastian Garcia Marti
Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis. Revista peruana de medicina experimental y salud publica 41 (1) (2024)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy 12 (2) (2022)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy 12 (2) (2022)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy (2022)
Sebastian Garcia Marti, Luz Gibbons, Sara Reidel, Juan Andrés Stupka, Juan Ignacio Degiuseppe, Fernando J Argento, Jorge A Gomez
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina. Infectious diseases and therapy 12 (2) (2022)
Agustín Ciapponi, Ariel Esteban Bardach, Agustina Mazzoni, Tomás Alconada, Steven Anderson, Fernando J Argento, Jamile Ballivian, Karin Bok, Daniel Comandé, Emily Erbelding, Erin Goucher, Beate Kampmann, Ruth Karron, Flor Muñoz Rivas, María Carolina Palermo, Edward P K Parker, Federico Rodriguez Cairoli, María Victoria Santa, Andy Stergachis, Gerald Voss, Xu Xiong, Natalia Zamora, Sabra Zaraa, Mabel Berrueta, Pierre M Buekens
Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review. medRxiv : the preprint server for health sciences (2021)